Receive a FREE Mesothelioma Treatment
Information Packet

Mesothelioma

Treatment Centers

ALABAMA

Birmingham: University of Alabama
Clinical research is being conducted on the use of a ribonuclease protein + doxorubicin vs. doxorubicin, in patients with unresectable malignant mesothelioma cancer.
Contact:
Karen Harper, RN, BSN
University of Alabama at Birmingham Comprehensive Cancer Center
1824 Sixth Avenue South
Birmingham, AL 35294-3300
Telephone: 205-934-5092
Email: Karen.Harper@ccc.uab.edu

CALIFORNIA

Los Angeles: Tower Hematology/Oncology
Study of an investigational treatment for malignant mesothelioma patients.
Contact:
Dee Volkerts, Study Coordinator
Tower Hematology/Oncology
8635 West Third Street, Suite 665W
Los Angeles, CA 90048
San Diego: Sharp Health Care
Study of an investigational treatment for malignant mesothelioma patients.
Contact:
Cathy K. Wood, Manager, Oncology Research Program
Sharp Health Care
10835 Road to the Cure
San Diego, CA 92121
Telephone: 858-450-5990 ext. 221

COLORADO


Denver: University of Colorado
Study of an investigational treatment for malignant mesothelioma patients.
Contact:
Monica Robischon, Study Coordinator
University of Colorado
4200 East 9th Avenue, B-189
Denver, CO 80262
Telephone: 303-372-9108

FLORIDA


Miami: Oncology Hematology Group of South Florida
Study of an investigational treatment for malignant mesothelioma patients.
Contact:
Cathy Maxwell, Study Coordinator
Oncology Hematology Group of South Florida
8940 North Kendall Drive, Suite 300E
Miami, FL 33176
Telephone: 305-594-2141 ext. 286

ILLNOIS


Chicago: University of Chicago Medical Center
Study of an investigational treatment for malignant mesothelioma patients.
Contact:
Tamara Guterz, Study Coordinator
University of Chicago Medical Center, Section of Hematology/Oncology
5841 S. Maryland Avenue, MC2115
Chicago, IL 60637-1470
Telephone: 773-834-3137

KENTUCKY

Louisville: Kentuckiana Cancer Institute
Study of an investigational treatment for malignant mesothelioma patients.
Contact:
Roxanne Smalley
Kentuckiana Cancer Institute
100 E. Liberty Street, Suite 502
Louisville, KY 40202
Telephone: 502-561-8200

MASSACHUSETTS

Worcester: Umass Memorial Cancer Center
Study of an investigational treatment for malignant mesothelioma patients
Contact:
Carolyn Gustison, RN, OCN, Study Coordinator
Umass Memorial Cancer Center
Division of Hematology/Oncology
55 Lake Avenue North
Worcester, MA 01655-001
Telephone: 508-856-1385
Email: judith.odonnell@banyan.ummed.edu

NEW JERSEY

Somerville: Somerset Medical Center
Study of an investigational treatment for malignant mesothelioma patients.
Contact:
Oncology Clinical Research Coordinator
Somerset Medical Center
110 Rehill Avenue
Somerville, NJ 08876
Telephone: 908-685-2481
Email: jcraig@somerset-healthcare.com

NEW YORK

New York City: Columbia-Presbyterian Medical Center
Phase II trial of combined resection, intraperitoneal chemotherapy, and whole abdominal radiation for treatment of peritoneal mesothelioma.
Contact:
Mary Hesdorffer, RN, BSN, Clinical Research Nurse
Columbia-Presbyterian Medical Center
161 Fort Washington Avenue
New York, NY 10032
Telephone: 212-305-1252

PENNSYLVANIA

Philadelphia: Presbyterian Medical Center, University of PA Health System
Study of an investigational treatment for malignant mesothelioma patients.
Contact:
Pat Drobins, Study Coordinator
Presbyterian Medical Center, U. PA Health System
Medical Arts Building
51 North 39th Street
Philadelphia, PA 19104
Telephone: 215-349-8913

TENNESSEE

Knoxville: Thompson Cancer Survival Center
Study of an investigational treatment for malignant mesothelioma patients
Contact:
Sue Thompson, RN, Manager, Clinical Trials
Thompson Cancer Survival Center
1915 White Avenue
Knoxville, TN 37916
Telephone: 865-541-1893
Email: sbales@corhlth.com

TEXAS

Austin: Lone Star Oncology
Study of an investigational treatment for malignant mesothelioma patients.
Contact:
Tracy Bell, Study Coordinator
Lone Star Oncology
11044 Research Boulevard, Suite D400
Austin, TX 78759
Telephone: 512-343-2103
Email: drjjjc@aol.com

Houston: S. R. Burzynski Clinic
Phase II Study Of Antineoplastons A10 And AS2-1 In Patients With Mesothelioma
Contact:
Oncology Department
S. R. Burzynski Clinic
9432 Old Katy, Suite 200
Houston, TX 77055
Telephone: 713-335-5697
Email: info@burzynskiclinic.com
Houston: MD Anderson Cancer Center
Study of an investigational treatment for malignant mesothelioma patients.
Contact:
Oncology Department
MD Anderson Cancer Center
Department of Thoracic Head & Neck Med Onc, Box 432
1515 Holcombe Boulevard
Houston, TX 77030
Telephone: 713-792-7033 ext. 3141

VIRGINIA

Charlottesville: H.O.P.E.
Study of an investigational treatment for malignant mesothelioma patients.
Contact:
Hematology Oncology Department
H.O.P.E.
459 Locust Ave.
Charlottesville, VA 22902
Telephone: 434-982-8410
Newport News: Virginia Oncology Associates
Study of an investigational treatment for malignant mesothelioma patients.
Contact:
Virginia Oncology Associates
895 Middle Ground Boulevard #200
Newport News, VA 23606
Telephone: 757-873-9400